These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 15158611

  • 1. Cross-linking of CD40 using anti-CD40 antibody, 5C11, has different effects on XG2 multiple myeloma cells.
    Qi CJ, Zheng L, Zhou X, Tao Y, Ge Y, Zhuang YM, Xu Y, Yu G, Zhang XG.
    Immunol Lett; 2004 May 15; 93(2-3):151-8. PubMed ID: 15158611
    [Abstract] [Full Text] [Related]

  • 2. Sensitization of multiple myeloma and B lymphoma lines to dexamethasone and gamma-radiation-induced apoptosis by CD40 activation.
    Zhou ZH, Shi Q, Wang JF, Chen YJ, Zhuang YM, Pan JZ, Xu CS, Qi CJ, Zhang XG.
    Apoptosis; 2005 Jan 15; 10(1):123-34. PubMed ID: 15711928
    [Abstract] [Full Text] [Related]

  • 3. CD40 signaling activated by agonistic anti-CD40 monoclonal antibody 5C11 has different effects on biological behavior of gastric carcinoma cells.
    Li R, Chen WC, Wang WP, Tian WY, Zhang XG.
    Immunol Lett; 2010 Jul 08; 131(2):120-5. PubMed ID: 20188757
    [Abstract] [Full Text] [Related]

  • 4. An agonist anti-human CD40 monoclonal antibody that induces dendritic cell formation and maturation and inhibits proliferation of a myeloma cell line.
    Zhou ZH, Wang JF, Wang YD, Qiu YH, Pan JZ, Xie W, Jiang LY, Klein B, Zhang XG.
    Hybridoma; 1999 Dec 08; 18(6):471-8. PubMed ID: 10626675
    [Abstract] [Full Text] [Related]

  • 5. CD11a-CD18 and CD102 interactions mediate human myeloma cell growth arrest induced by CD40 stimulation.
    Pellat-Deceunynck C, Amiot M, Robillard N, Wijdenes J, Bataille R.
    Cancer Res; 1996 Apr 15; 56(8):1909-16. PubMed ID: 8620513
    [Abstract] [Full Text] [Related]

  • 6. Immunomodulatory drug lenalidomide (CC-5013, IMiD3) augments anti-CD40 SGN-40-induced cytotoxicity in human multiple myeloma: clinical implications.
    Tai YT, Li XF, Catley L, Coffey R, Breitkreutz I, Bae J, Song W, Podar K, Hideshima T, Chauhan D, Schlossman R, Richardson P, Treon SP, Grewal IS, Munshi NC, Anderson KC.
    Cancer Res; 2005 Dec 15; 65(24):11712-20. PubMed ID: 16357183
    [Abstract] [Full Text] [Related]

  • 7. CD40 expression in malignant plasma cells. Role in stimulation of autocrine IL-6 secretion by a human myeloma cell line.
    Westendorf JJ, Ahmann GJ, Armitage RJ, Spriggs MK, Lust JA, Greipp PR, Katzmann JA, Jelinek DF.
    J Immunol; 1994 Jan 01; 152(1):117-28. PubMed ID: 7504707
    [Abstract] [Full Text] [Related]

  • 8. A novel blocking monoclonal antibody recognizing a distinct epitope of human CD40 molecule.
    Zhuang Y, Huang J, Zhou Z, Ge Y, Fan Y, Qi C, Zhen L, Monchatre E, Edelman L, Zhang X.
    Tissue Antigens; 2005 Jan 01; 65(1):81-7. PubMed ID: 15663744
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of lung cancer cell proliferation by CD40 signaling through tumor necrosis factor I.
    Lu XD, Zhu XL, Chen C, Zhang GB, Zhang XG, Huang JA.
    Ai Zheng; 2009 Jan 01; 28(1):20-3. PubMed ID: 19448410
    [Abstract] [Full Text] [Related]

  • 10. Preclinical antilymphoma activity of a humanized anti-CD40 monoclonal antibody, SGN-40.
    Law CL, Gordon KA, Collier J, Klussman K, McEarchern JA, Cerveny CG, Mixan BJ, Lee WP, Lin Z, Valdez P, Wahl AF, Grewal IS.
    Cancer Res; 2005 Sep 15; 65(18):8331-8. PubMed ID: 16166310
    [Abstract] [Full Text] [Related]

  • 11. Novel role of CD40 in Fas-dependent apoptosis of cultured salivary epithelial cells from patients with Sjögren's syndrome.
    Ping L, Ogawa N, Sugai S.
    Arthritis Rheum; 2005 Feb 15; 52(2):573-81. PubMed ID: 15692983
    [Abstract] [Full Text] [Related]

  • 12. [Anti-CD40 McAb induces CD40+ malignant B cell proliferation arrest and apoptosis].
    Zhou Z, Shi Q, Wang J, Pan J, Zhang X.
    Zhonghua Xue Ye Xue Za Zhi; 2000 May 15; 21(5):237-9. PubMed ID: 11876986
    [Abstract] [Full Text] [Related]

  • 13. Interference with nuclear factor kappa B and c-Jun NH2-terminal kinase signaling by TRAF6C small interfering RNA inhibits myeloma cell proliferation and enhances apoptosis.
    Chen H, Li M, Campbell RA, Burkhardt K, Zhu D, Li SG, Lee HJ, Wang C, Zeng Z, Gordon MS, Bonavida B, Berenson JR.
    Oncogene; 2006 Oct 19; 25(49):6520-7. PubMed ID: 16702955
    [Abstract] [Full Text] [Related]

  • 14. Differential effect of prostaglandins E1 and E2 on lipopolysaccharide-induced adhesion molecule expression on human monocytes.
    Takahashi HK, Iwagaki H, Tamura R, Katsuno G, Xue D, Sugita S, Mori S, Yoshino T, Tanaka N, Nishibori M.
    Eur J Pharmacol; 2005 Apr 11; 512(2-3):223-30. PubMed ID: 15840408
    [Abstract] [Full Text] [Related]

  • 15. Delineation of the roles of paracrine and autocrine interleukin-6 (IL-6) in myeloma cell lines in survival versus cell cycle. A possible model for the cooperation of myeloma cell growth factors.
    Jourdan M, Mahtouk K, Veyrune JL, Couderc G, Fiol G, Redal N, Duperray C, De Vos J, Klein B.
    Eur Cytokine Netw; 2005 Apr 11; 16(1):57-64. PubMed ID: 15809207
    [Abstract] [Full Text] [Related]

  • 16. Tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) in B-lymphocyte function.
    Rieckmann P, Tuscano JM, Kehrl JH.
    Methods; 1997 Jan 11; 11(1):128-32. PubMed ID: 8990098
    [Abstract] [Full Text] [Related]

  • 17. A novel mutation in CD40 and its functional characterization.
    Qi CJ, Zheng L, Ma HB, Fei M, Qian KQ, Shen BR, Wu CP, Vihinen M, Zhang XG.
    Hum Mutat; 2009 Jun 11; 30(6):985-94. PubMed ID: 19479954
    [Abstract] [Full Text] [Related]

  • 18. The influence of alpha1-antagonist on the expression pattern of TNF receptor family in primary culture of prostate epithelial cells from BPH patients.
    Drewa T, Wolski Z, Misterek B, Debski R, Styczynski J.
    Prostate Cancer Prostatic Dis; 2008 Jun 11; 11(1):88-93. PubMed ID: 17533395
    [Abstract] [Full Text] [Related]

  • 19. Induction of CD40 expression and enhancement of monoclonal antibody production on murine B cell hybridomas by cross-linking of IgG receptors.
    Martín-López A, García-Camacho F, Belarbi el H, Martínez-Escobar S, Contreras-Gómez A, Molina-Grima E.
    Biotechnol Prog; 2007 Jun 11; 23(2):452-7. PubMed ID: 17326658
    [Abstract] [Full Text] [Related]

  • 20. Human anti-CD40 antagonist antibody triggers significant antitumor activity against human multiple myeloma.
    Tai YT, Li X, Tong X, Santos D, Otsuki T, Catley L, Tournilhac O, Podar K, Hideshima T, Schlossman R, Richardson P, Munshi NC, Luqman M, Anderson KC.
    Cancer Res; 2005 Jul 01; 65(13):5898-906. PubMed ID: 15994968
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.